Czech Republic records 97 cases of adverse reactions to swine flu vaccine
2010-01-08
The Czech medicines agency (SUKL) has, so far, recorded 97 cases of suspected adverse drug reactions associated with the swine flu vaccine Pandemrix, since the beginning of the inoculation campaign on 23 November 2009. The most frequent adverse reactions were flu-like symptoms (44 cases) and localised skin reaction to the vaccination - 34 cases reported since the beginning of the vaccination programme.
According to the European Medicines Agency (EMEA), 26 million people in the EU have, so far, been vaccinated with three EU-wide authorised vaccines: Pandemrix (GlaxoSmithKline), Celvapan (Baxter) and Focetria (Novartis).
1 year subscription to internet service providing market news and analytical articles
Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
12-month subscription (26 issues of biweekly news)
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.